An interventional study of water-filtered Infrared-A radiation in Hand Osteoarthritis, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-03-28.
Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 131 studies in Osteoarthritis with a site in Germany — 12 open to participants now, 27 under way, 3 of them phase 3. Osteoarthritis · Germany.
Among the 131 studies in Osteoarthritis with a site in Germany, this one is the 67th largest by planned enrollment of the 98 interventional ones that give a count, is one of 6 that started in 2024, is one of 36 with no phase, reaches primary completion later than 5 of the 26 other live ones, and was the 121st registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →12 of the 131 studies in Osteoarthritis with a site in Germany are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Germany, United States, Argentina and 10 more countries
Ages 18+
University Hospital, Basel, Switzerland · Sites in Germany, Austria, Croatia and 5 more countries
Ages 18–70
Charite University, Berlin, Germany · Sites in Germany
Ages 18–50
University Hospital, Basel, Switzerland · Sites in Germany, Croatia, Switzerland
Ages 18–65
Waldfriede Hospital · Sites in Germany
Ages 18–90
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
131 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 24 · Phase 3 23 · Phase 4 12
First in 2000; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is below the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 139 across the 98 interventional studies, 100 across the 31 observational. Of the 96 that completed or were terminated, 28 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
94 of 131 have an industry lead sponsor. The 10 most frequent:
Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Charite University, Berlin, Germany has 4 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
7 of the studies in Osteoarthritis with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07352540Phase 3University of Erlangen-Nürnberg Medical SchoolSingle vs Triple Hyaluronic Acid in Knee Osteoarthritis | 2026-12-15 |
| NCT02337244Zimmer, GmbHZimmer POLAR Persona - TKA (EMEA Study) | 2026-12 |
| NCT02351414MicroPort Orthopedics Inc.Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | 2027-06 |
| NCT02823834MicroPort Orthopedics Inc.PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components | 2027-06 |
| NCT02038140Zimmer BiometZimmer Trabecular Metal Total Ankle PMCF | 2027-09 |
Add all 7 to your calendar (.ics) → With an account.
Among the 131 studies in Osteoarthritis with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this clinical trial is to evaluate the effects of water-filtered Infrared-A radiation on patients suffering from hand osteoarthritis. The main questions it aims to answer are:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the intervention group each receive a hyperthermia device for water-filtered Infrared-A radiation.
Device: water-filtered Infrared-A radiation
Participants in the control group initially receive no therapeutic intervention, but can receive it after the study's last visit for 3 months.
The water-filtered Infrared-A radiation device is designed for self-administered home treatments. The regimen prescribes 30-minute sessions, five times weekly, spanning 12 weeks.
Pain in the finger joints on visual analogue scale
Average pain in the finger joints over the last 7 days after 12 weeks compared to baseline on the Visual Analog Scale (VAS, 0-100mm) compared to the waiting list control group.
Time frame: Baseline, 12 weeks
Hand Dynamometer
Grip strength measured using a Hand Dynamometer (SAEHAN Corporation)
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Disabilities of Arm, Shoulder and Hand (DASH) questionnaire
Assessing full scale, range 0-100, higher score meaning a better outcome
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Pain Self-Efficacy Questionnaire
Assessing full scale, range 0-100, higher score meaning a better outcome
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Hospital Anxiety and Depression Scale (HADS)
Assessing full scale, range 0-100, higher score meaning a better outcome
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Short Form (SF)-36 Health Survey (SF-36)
Assessing full scale, range 0-100, higher score meaning a better outcome
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Functional Index for Hand OsteoArthritis (FIHOA)
Assessing functional impairment, scoring from 0 (no functional impairment) to 30 points (maximal impairment).
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Tolerability of the intervention
Monitoring tolerability of the intervention (5-point Likert scale, 1=very good tolerability to 5=very bad tolerability)
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Pain medication (number per day)
Documenting changes in pain medication and pain medication on demand
Time frame: Baseline, 6 weeks, 12 weeks, 24 weeks
Started Mar 2024 (actual). Primary completion is estimated for Feb 2025, 11 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 11 months is below that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →